Thomas N Darling

Dr. Thomas N Darling serves as Professor and Chair of Dermatology at Uniformed Services University of the Health Sciences (USUHS) School of Medicine, with secondary appointments in Anatomy/Physiology/Genetics and Molecular/Cell Biology. His 25-year career at USUHS spans roles from Assistant Professor (1999) to current Department Chair (2014-present), following clinical training at Duke University and NIH.

His educational background includes:

• B.S. in Biology, Houghton College (1979-1983)
• M.D.-Ph.D., Duke University (1983-1990)
• Medicine Internship, UNC Hospitals (1990-1991)
• Dermatology Residency, Duke University Medical Center (1991-1994)
• Clinical Fellow, NIH Dermatology Branch (1994-1998)

Dr. Darling's research focuses on the genetic mechanisms of skin tumors in tuberous sclerosis complex (TSC), with expertise in somatic mutations, PI3K-AKT1 pathway disorders, and skin regeneration. His work bridges clinical dermatology and molecular genetics to develop targeted therapies for genodermatoses.

Analysis of his 2014-2023 publications reveals consistent focus on TSC pathogenesis, with increasing emphasis on next-generation sequencing diagnostics and mTOR inhibitor therapeutics. His research demonstrates strong NIH collaboration and clinical translation from genetic discovery to treatment protocols.

His scientific awards include:

• James Leonard Award for Clinical Research Excellence (2009)
• NHGRI GREAT Award for Proteus syndrome discovery (2012)
• NHGRI GREAT Award for PI3K-AKT1 pathway disorders (2013)
• NHLBI Orloff Science Award for LAM/TSC tumor cell research (2016)

Dr. Darling leads USUHS dermatology research through collaborations with NHGRI and NHLBI, contributing to international TSC consensus guidelines. His work integrates military medical priorities with cutting-edge genomic dermatology, though specific lab structures aren't detailed in available materials.

No information on student advising or grant funding is provided in the source materials.